Babak Tousi

718 total citations
31 papers, 376 citations indexed

About

Babak Tousi is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, Babak Tousi has authored 31 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 12 papers in Neurology and 7 papers in Physiology. Recurrent topics in Babak Tousi's work include Dementia and Cognitive Impairment Research (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Alzheimer's disease research and treatments (6 papers). Babak Tousi is often cited by papers focused on Dementia and Cognitive Impairment Research (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Alzheimer's disease research and treatments (6 papers). Babak Tousi collaborates with scholars based in United States, Norway and Italy. Babak Tousi's co-authors include Marwan N. Sabbagh, James B. Leverenz, Andrew P. Keegan, Marc Agronin, Charles Bernick, Stella Karantzoulis, Gustavo Alva, Álvaro Pascual‐Leone, Carmel Armon and Carl Sadowsky and has published in prestigious journals such as Neurology, PLoS Medicine and Journal of Alzheimer s Disease.

In The Last Decade

Babak Tousi

29 papers receiving 367 citations

Peers

Babak Tousi
Ludwig Trillo United States
Ashwin Venkataraman United Kingdom
Jeffery L. Cummings United States
Jing Ping China
Randolph D. Andrews United States
Gus Alva United States
Ludwig Trillo United States
Babak Tousi
Citations per year, relative to Babak Tousi Babak Tousi (= 1×) peers Ludwig Trillo

Countries citing papers authored by Babak Tousi

Since Specialization
Citations

This map shows the geographic impact of Babak Tousi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babak Tousi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babak Tousi more than expected).

Fields of papers citing papers by Babak Tousi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Babak Tousi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babak Tousi. The network helps show where Babak Tousi may publish in the future.

Co-authorship network of co-authors of Babak Tousi

This figure shows the co-authorship network connecting the top 25 collaborators of Babak Tousi. A scholar is included among the top collaborators of Babak Tousi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Babak Tousi. Babak Tousi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Yuan, Bo Hu, Andrew A. Pieper, et al.. (2025). Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer’s disease: A systematic review and meta-analysis. PLoS Medicine. 22(3). e1004568–e1004568. 4 indexed citations
2.
Matthews, Dawn, Jefferson W. Kinney, Aaron Ritter, et al.. (2024). Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12490–e12490. 6 indexed citations
4.
Tousi, Babak, et al.. (2022). Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update. Drugs & Aging. 39(7). 505–522. 14 indexed citations
5.
Matthews, Dawn, Aaron Ritter, Ronald G. Thomas, et al.. (2021). Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia. Alzheimer s & Dementia Translational Research & Clinical Interventions. 7(1). e12106–e12106. 32 indexed citations
6.
Tousi, Babak, et al.. (2021). The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data. Drug Design Development and Therapy. Volume 15. 1811–1817. 4 indexed citations
7.
Unger, Robert, et al.. (2020). Neurodegenerative Outcomes Following Diagnosis of REM Sleep Behavior Disorder or Isolated REM Sleep Without Atonia (2746). Neurology. 94(15_supplement). 1 indexed citations
8.
Pillai, Jagan A., Guiyun Wu, Babak Tousi, et al.. (2019). Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies. Parkinsonism & Related Disorders. 64. 300–303. 8 indexed citations
9.
Unger, Robert, et al.. (2019). Color Vision Impairment in Prodromal and Dementia Stages of Lewy Body Disease versus Alzheimer’s Disease (P4.1-027). Neurology. 92(15_supplement). 1 indexed citations
10.
Tousi, Babak, et al.. (2018). 5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress. Neurology and Therapy. 7(1). 51–58. 37 indexed citations
11.
Flanigan, Patrick M., et al.. (2018). Color Vision Impairment Differentiates Alzheimer Dementia From Dementia With Lewy Bodies. Journal of Geriatric Psychiatry and Neurology. 31(2). 97–102. 17 indexed citations
12.
Tousi, Babak. (2017). Diagnosis and Management of Cognitive and Behavioral Changes in Dementia With Lewy Bodies. Current Treatment Options in Neurology. 19(11). 42–42. 10 indexed citations
13.
Yamamoto, Erin, et al.. (2017). Utility of Montreal Cognitive Assessment in Differentiating Dementia With Lewy Bodies From Alzheimer’s Dementia. American Journal of Alzheimer s Disease & Other Dementias®. 32(8). 468–471. 9 indexed citations
14.
Tousi, Babak. (2015). The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence. Neuropsychiatric Disease and Treatment. 11. 311–311. 50 indexed citations
15.
Tousi, Babak, et al.. (2014). Don’t forget non-Alzheimer dementias. Cleveland Clinic Journal of Medicine. 81(4). 243–254. 6 indexed citations
16.
Tousi, Babak & Kathy Wilson. (2012). Falls Related to Accidental Deactivation of Deep Brain Stimulators in Patients With Parkinson's Disease Living in Long Term Care Facilities. Journal of the American Medical Directors Association. 14(1). 58–59. 1 indexed citations
17.
Tousi, Babak. (2008). Movement disorder emergencies in the elderly: Recognizing and treating an often-iatrogenic problem. Cleveland Clinic Journal of Medicine. 75(6). 449–457. 7 indexed citations
18.
Tousi, Babak, Stephan Schuele, & Thyagarajan Subramanian. (2005). A 46-year-old woman with rigidity and frequent falls.. Cleveland Clinic Journal of Medicine. 72(1). 57–63. 2 indexed citations
19.
Tousi, Babak, et al.. (2004). Olfactory and visual hallucinations in Parkinson's disease. Parkinsonism & Related Disorders. 10(4). 253–254. 27 indexed citations
20.
Tousi, Babak, et al.. (2002). Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine. Clinical & Laboratory Haematology. 24(4). 259–260. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026